Table 3.
Particle size (nm) | Polydispersity index | Encapsulation efficiency (%) | |
---|---|---|---|
NPs | 70.5±0.8 | 0.11±0.03 | / |
cHP-NPs | 80.1±2.4 | 0.17±0.05 | / |
Cur-NPs | 78.6±1.5 | 0.18±0.06 | 86.08±2.58 |
cHP/Cur-NPs | 97.3±1.7 | 0.16±0.04 | 80.52±2.39 |
Cou-NPs | 71.5±2.9 | 0.19±0.05 | 92.21±3.56 |
cHP/Cou-NPs | 82.9±3.6 | 0.25±0.08 | 86.33±1.98 |
DiR-NPs | 70.8±2.0 | 0.18±0.05 | 91.58±4.58 |
cHP/DiR-NPs | 78.2±3.6 | 0.22±0.07 | 83.24±2.43 |
Note: “/”indicates not applicable.
Abbreviations: cHP, cyclic hexapeptide, c(RGDf(N-me)VK)-C; cHP/Cou-NPs, cHP-modified coumarin nanoparticles; cHP/Cur-NPs, cHP-modified curcumin nanoparticles; cHP/DiR-NPs, cHP-modified DiR nanoparticles; cHP-NPs, cHP-modified nanoparticles; Cou-NPs, coumarin nanoparticles; Cur-NPs, curcumin nanoparticles; DiR, 1,1′-Dioctadecyl-3,3,3′,3′-tetramethylindotricarbocyanine; DiR-NPs, DiR nanoparticles; NPs, nanoparticles.